glp-1 agonists weight loss drugs market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Medications for Weight Loss:
Description
4,6 Efficacy A1C-Lowering Effects: Compared with other oral antihyperglycemic agents, DPP-4 inhibitors are considered to have intermediate glycemic efficacy
The impact of this class on the risk of cardiac failure is still under investigation
For weight loss, the main options are Wegovy (semaglutide), Saxenda (liraglutide), and Mounjaro (tirzepatide)
van Raalte, D
Bumps and Humps in the Success of Tirzepatide as the First GLP1 and GIP Receptor Agonist
